Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 514

1.

Identification of cells expressing two peptidoglycan recognition proteins in the gill of the vent mussel, Bathymodiolus septemdierum.

Ikuta T, Tame A, Saito M, Aoki Y, Nagai Y, Sugimura M, Inoue K, Fujikura K, Ohishi K, Maruyama T, Yoshida T.

Fish Shellfish Immunol. 2019 Oct;93:815-822. doi: 10.1016/j.fsi.2019.08.022. Epub 2019 Aug 13.

2.

Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk.

Suzuki K, Wada H, Matsumoto T, Ikejiri M, Ohishi K, Yamashita Y, Imai H, Iba T, Katayama N.

Thromb J. 2019 Jun 28;17:12. doi: 10.1186/s12959-019-0201-0. eCollection 2019.

3.

Marine Morbilliviruses: Diversity and Interaction with Signaling Lymphocyte Activation Molecules.

Ohishi K, Maruyama T, Seki F, Takeda M.

Viruses. 2019 Jul 3;11(7). pii: E606. doi: 10.3390/v11070606.

4.

The extent of DNA methylation anticipation due to a genetic defect in ICR1 in Beckwith-Wiedemann syndrome.

Sun F, Higashimoto K, Awaji A, Ohishi K, Nishizaki N, Tanoue Y, Aoki S, Watanabe H, Yatsuki H, Soejima H.

J Hum Genet. 2019 Sep;64(9):937-943. doi: 10.1038/s10038-019-0634-0. Epub 2019 Jun 24.

PMID:
31235774
5.

Infiltrating CCR2+ monocytes and their progenies, fibrocytes, contribute to colon fibrosis by inhibiting collagen degradation through the production of TIMP-1.

Kuroda N, Masuya M, Tawara I, Tsuboi J, Yoneda M, Nishikawa K, Kageyama Y, Hachiya K, Ohishi K, Miwa H, Yamada R, Hamada Y, Tanaka K, Kato T, Takei Y, Katayama N.

Sci Rep. 2019 Jun 12;9(1):8568. doi: 10.1038/s41598-019-45012-6.

6.

A population of CD20+CD27+CD43+CD38lo/int B1 cells in PNH are missing GPI-anchored proteins and harbor PIGA mutations.

Kageyama Y, Miwa H, Tawara I, Ohishi K, Masuya M, Katayama N.

Blood. 2019 Jul 4;134(1):89-92. doi: 10.1182/blood.2019001343. Epub 2019 May 21. No abstract available.

PMID:
31113778
7.

Evaluation of Medication Adherence and Pharmacokinetics of Dasatinib for Earlier Molecular Response in Japanese Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Pilot Study.

Iwamoto T, Monma F, Ohishi K, Umino A, Suzuki K, Oka K, Kawakami K, Sekine T, Okuda M, Katayama N.

Ther Drug Monit. 2019 Oct;41(5):575-581. doi: 10.1097/FTD.0000000000000639.

PMID:
31008998
8.

A Japanese family with cone-rod dystrophy of delayed onset caused by a compound heterozygous combination of novel CDHR1 frameshift and known missense variants.

Haque MN, Kurata K, Hosono K, Ohtsubo M, Ohishi K, Sato M, Minoshima S, Hotta Y.

Hum Genome Var. 2019 Apr 12;6:18. doi: 10.1038/s41439-019-0048-8. eCollection 2019.

9.

Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy.

Yamashita Y, Suzuki K, Mastumoto T, Ikejiri M, Ohishi K, Katayama N, Suzuki-Inoue K, Wada H.

Thromb Res. 2019 Jun;178:54-58. doi: 10.1016/j.thromres.2019.03.018. Epub 2019 Mar 28.

PMID:
30978634
10.

[A Case of a Duodenal GIST Observed as a Non-Functional Pancreatic Neuroendocrine Tumor].

Fukuchi N, Ebisui C, Minoji T, Takabatake H, Tamai K, Kitahara T, Watanabe N, Yamamura N, Okamura S, Yokouchi H, Ohishi K, Kinuta M.

Gan To Kagaku Ryoho. 2019 Mar;46(3):589-591. Japanese.

PMID:
30914623
11.

Topological transitions among skyrmion- and hedgehog-lattice states in cubic chiral magnets.

Fujishiro Y, Kanazawa N, Nakajima T, Yu XZ, Ohishi K, Kawamura Y, Kakurai K, Arima T, Mitamura H, Miyake A, Akiba K, Tokunaga M, Matsuo A, Kindo K, Koretsune T, Arita R, Tokura Y.

Nat Commun. 2019 Mar 5;10(1):1059. doi: 10.1038/s41467-019-08985-6.

12.

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor.

Matsumoto T, Wada H, Ohishi K, Yamashita Y, Ikejiri M, Katayama N.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618824419. doi: 10.1177/1076029618824419. No abstract available.

13.

[A Case of Extramedullary Plasmacytoma of the Stomach Detected Due to Severe Anemia].

Tamai K, Ebisui C, Yamamura N, Minoji T, Takabatake H, Kitahara T, Watanabe N, Okamura S, Fukuchi N, Yokouchi H, Kinuta M, Ohishi K.

Gan To Kagaku Ryoho. 2019 Jan;46(1):100-102. Japanese.

PMID:
30765654
14.

[A Case of Long-Term Control of Stage Ⅳ Gastric Cancer by Multimodal Therapy].

Ebisui C, Yamamura N, Minoji T, Takabatake H, Tamai K, Kitahara T, Watanabe N, Okamura S, Fukuchi N, Yokouchi H, Kinuta M, Ohishi K.

Gan To Kagaku Ryoho. 2019 Jan;46(1):97-99. Japanese.

PMID:
30765653
15.

[Resection of a Desmoid Tumor Originating from the Greater Omentum after Surgery for Colon Cancer and Liver Metastasis-A Case Report].

Okamura S, Kitahara T, Tamai K, Minoji T, Takabatake H, Watanabe N, Yamamura N, Fukuchi N, Ebisui C, Yokouchi H, Ohishi K, Kinuta M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2444-2446. Japanese.

PMID:
30692492
16.

Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: comment.

Wada H, Matsumoto T, Yamashita Y, Ohishi K, Ikejiri M, Katayama N.

J Thromb Haemost. 2019 Mar;17(3):555-556. doi: 10.1111/jth.14395. Epub 2019 Feb 27. No abstract available.

PMID:
30672649
17.

Expression of CD25 fluctuates in the leukemia-initiating cell population of CD25-positive AML.

Kageyama Y, Miwa H, Arakawa R, Tawara I, Ohishi K, Masuya M, Nakase K, Katayama N.

PLoS One. 2018 Dec 14;13(12):e0209295. doi: 10.1371/journal.pone.0209295. eCollection 2018.

18.

Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients.

Sasaki T, Franco OE, Ohishi K, Filipovich Y, Ishii K, Crawford SE, Takahashi N, Katayama N, Sugimura Y, Hayward SW.

Prostate. 2019 Feb;79(3):259-264. doi: 10.1002/pros.23730. Epub 2018 Oct 28.

PMID:
30370673
19.

Detection of serum antibodies to Brucella in Russian aquatic mammals.

Ohishi K, Abe E, Amano M, Miyazaki N, Boltunov A, Katsumata E, Maruyama T.

J Vet Med Sci. 2018 Nov 9;80(11):1696-1701. doi: 10.1292/jvms.18-0330. Epub 2018 Sep 5.

20.

Case of human immunodeficiency virus infection presenting as a tip variant of focal segmental glomerulosclerosis: A case report and review of the literature.

Goto D, Ohashi N, Takeda A, Fujigaki Y, Shimizu A, Yasuda H, Ohishi K.

World J Nephrol. 2018 Aug 7;7(4):90-95. doi: 10.5527/wjn.v7.i4.90.

21.

Neutron scattering studies on short- and long-range layer structures and related dynamics in imidazolium-based ionic liquids.

Nemoto F, Kofu M, Nagao M, Ohishi K, Takata SI, Suzuki JI, Yamada T, Shibata K, Ueki T, Kitazawa Y, Watanabe M, Yamamuro O.

J Chem Phys. 2018 Aug 7;149(5):054502. doi: 10.1063/1.5037217.

PMID:
30089384
22.

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan.

Takahashi N, Nishiwaki K, Nakaseko C, Aotsuka N, Sano K, Ohwada C, Kuroki J, Kimura H, Tokuhira M, Mitani K, Fujikawa K, Iwase O, Ohishi K, Kimura F, Fukuda T, Tanosaki S, Takahashi S, Kameoka Y, Nishikawa H, Wakita H; STAT study group.

Haematologica. 2018 Nov;103(11):1835-1842. doi: 10.3324/haematol.2018.194894. Epub 2018 Jul 5.

23.

Computational Analysis of the Interaction Energies between Amino Acid Residues of the Measles Virus Hemagglutinin and Its Receptors.

Xu F, Tanaka S, Watanabe H, Shimane Y, Iwasawa M, Ohishi K, Maruyama T.

Viruses. 2018 May 3;10(5). pii: E236. doi: 10.3390/v10050236.

24.

Congenital Thrombophilia in Patients With Superior Mesenteric Venous Thrombosis or Portal Vein Thrombosis.

Makoto I, Usui M, Wada H, Matsumoto T, Ohishi K, Shindo A, Yamashita Y, Nakatani K, Tamaki S, Tomimoto H, Isaji S.

Clin Appl Thromb Hemost. 2018 Oct;24(7):1117-1121. doi: 10.1177/1076029618774146. Epub 2018 May 10.

25.

Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.

Noguchi S, Nakaseko C, Nishiwaki K, Ogasawara H, Ohishi K, Tokuhira M, Noguchi M, Kimura H, Handa H, Mitani K, Miura M, Wakita H, Takahashi N; STAT study group.

Int J Hematol. 2018 Aug;108(2):176-183. doi: 10.1007/s12185-018-2459-6. Epub 2018 Apr 30.

PMID:
29713954
26.

The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia.

Tsuji T, Ohishi K, Takeda A, Goto D, Sato T, Ohashi N, Fujigaki Y, Kato A, Yasuda H.

Clin Exp Nephrol. 2018 Dec;22(6):1300-1308. doi: 10.1007/s10157-018-1580-4. Epub 2018 Apr 26.

PMID:
29700702
27.

Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan.

Matsumoto T, Toyoda H, Amano K, Hirayama M, Ishikawa E, Fujimoto M, Ito M, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Kawamura N, Ikejiri M, Kawakami K, Miyata T, Wada H.

Clin Appl Thromb Hemost. 2018 Nov;24(8):1301-1307. doi: 10.1177/1076029618771750. Epub 2018 Apr 25.

28.

[Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].

Okano M, Matsumoto T, Nakamori Y, Ino K, Miyazaki K, Fujieda A, Sugimoto Y, Tawara I, Yamaguchi M, Ohishi K, Miwa H, Masuya M, Wada H, Katayama N.

Rinsho Ketsueki. 2018;59(2):178-181. doi: 10.11406/rinketsu.59.178. Japanese.

PMID:
29515070
29.

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform.

Katayama H, Matsumoto T, Wada H, Fujimoto N, Toyoda J, Abe Y, Ohishi K, Yamashita Y, Ikejiri M, Habe K, Katayama N.

Clin Appl Thromb Hemost. 2018 Oct;24(7):1170-1176. doi: 10.1177/1076029618757344. Epub 2018 Feb 13.

30.

[Curative Resection for Metastatic Lower Rectal Tumor from Ovarian Cancer - Report of a Case].

Okamura S, Noda H, Ohishi K, Kitahara T, Murata K, Minoji T, Hamano R, Yanagisawa T, Fukuchi N, Ebisui C, Yokouchi H, Nishizaki T, Kinuta M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1714-1716. Japanese.

PMID:
29394752
31.

[A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)].

Ebisui C, Hamano R, Minoji T, Kitahara T, Yanagisawa T, Okamura S, Fukuchi N, Murata K, Yokouchi H, Kinuta M, Ohishi K.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1263-1265. Japanese.

PMID:
29394601
32.

Discovery of a Novel Fluoroquinolone Antibiotic Candidate WFQ-228 with Potent Antimicrobial Activity and the Potential to Overcome Major Drug Resistance.

Hirano T, Kinoshita T, Kazamori D, Inoue S, Nishimura K, Sakurai A, Ohishi K, Kuramoto Y, Amano H, Yazaki A.

Chem Pharm Bull (Tokyo). 2018 Mar 1;66(3):235-238. doi: 10.1248/cpb.c17-00717. Epub 2018 Jan 11.

33.

Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis.

Oritani K, Ohishi K, Okamoto S, Kirito K, Komatsu N, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Okada H, Amagasaki T, Wakase S, Shimozuma K, Akashi K.

Curr Med Res Opin. 2018 Mar;34(3):531-537. doi: 10.1080/03007995.2017.1415874. Epub 2018 Jan 4.

PMID:
29224367
34.

The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis.

Habe K, Wada H, Higashiyama A, Akeda T, Tsuda K, Mori R, Kakeda M, Matsumoto T, Ohishi K, Yamanaka K, Katayama N, Mizutani H.

Clin Appl Thromb Hemost. 2018 Sep;24(6):920-927. doi: 10.1177/1076029617736382. Epub 2017 Nov 12.

35.

Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis.

Kirito K, Okamoto S, Ohishi K, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Oritani K, Akashi K, Okada H, Amagasaki T, Suzuki K, Yonezu T, Komatsu N.

Int J Hematol. 2018 Jan;107(1):92-97. doi: 10.1007/s12185-017-2332-z. Epub 2017 Oct 6.

PMID:
28986762
36.

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.

Takahashi N, Tauchi T, Kitamura K, Miyamura K, Saburi Y, Hatta Y, Miyata Y, Kobayashi S, Usuki K, Matsumura I, Minami Y, Usui N, Fukuda T, Takada S, Ishikawa M, Fujimaki K, Gomyo H, Sasaki O, Ohishi K, Miyake T, Imai K, Suzushima H, Mitsui H, Togitani K, Kiguchi T, Atsuta Y, Ohtake S, Ohnishi K, Kobayashi Y, Kiyoi H, Miyazaki Y, Naoe T; Japan Adult Leukemia Study Group.

Int J Hematol. 2018 Feb;107(2):185-193. doi: 10.1007/s12185-017-2334-x. Epub 2017 Sep 19.

PMID:
28929332
37.

An Evaluation of the Activated Partial Thromboplastin Time Waveform.

Matsumoto T, Wada H, Fujimoto N, Toyoda J, Abe Y MR, Ohishi K, Yamashita Y, Ikejiri M, Hasegawa K, Suzuki K, Imai H, Nakatani K, Katayama N.

Clin Appl Thromb Hemost. 2018 Jul;24(5):764-770. doi: 10.1177/1076029617724230. Epub 2017 Sep 8.

38.

Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform.

Hasegawa M, Wada H, Tone S, Yamaguchi T, Wakabayashi H, Ikejiri M, Watanabe M, Fujimoto N, Matsumoto T, Ohishi K, Yamashita Y, Katayama N, Sudo A.

Int J Lab Hematol. 2018 Feb;40(1):49-55. doi: 10.1111/ijlh.12727. Epub 2017 Sep 4.

PMID:
28869359
39.

CXCL12-CXCR4 Axis Is Required for Contact-Mediated Human B Lymphoid and Plasmacytoid Dendritic Cell Differentiation but Not T Lymphoid Generation.

Minami H, Nagaharu K, Nakamori Y, Ohishi K, Shimojo N, Kageyama Y, Matsumoto T, Sugimoto Y, Tawara I, Masuya M, Miwa H, Katayama N.

J Immunol. 2017 Oct 1;199(7):2343-2355. doi: 10.4049/jimmunol.1700054. Epub 2017 Aug 25.

40.

Varenicline promotes endothelial cell migration by lowering vascular endothelial-cadherin levels via the activated α7 nicotinic acetylcholine receptor-mitogen activated protein kinase axis.

Koga M, Kanaoka Y, Sugiyama K, Ohishi K, Ejima Y, Hisanaga M, Kataoka Y, Yamauchi A.

Toxicology. 2017 Sep 1;390:1-9. doi: 10.1016/j.tox.2017.08.006. Epub 2017 Aug 24.

PMID:
28842382
41.

Isolated thrombocytosis in chronic myeloid leukemia without significant leukocytosis.

Okano M, Sugimoto Y, Ohishi K, Miyazaki K, Monma F, Katayama N.

Rinsho Ketsueki. 2017;58(7):766-771. doi: 10.11406/rinketsu.58.766. Review. Japanese.

PMID:
28781272
42.

Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting.

Tanaka Y, Ohishi K, Sawai T, Iwasaki H, Kageyama S, Masuya M, Matsumoto T, Tanigawa T, Wada H, Shiku H, Ito M, Katayama N.

Ther Apher Dial. 2017 Oct;21(5):507-511. doi: 10.1111/1744-9987.12562. Epub 2017 Jul 21.

PMID:
28731276
43.

Intradiscal Injection of Autologous Platelet-Rich Plasma Releasate to Treat Discogenic Low Back Pain: A Preliminary Clinical Trial.

Akeda K, Ohishi K, Masuda K, Bae WC, Takegami N, Yamada J, Nakamura T, Sakakibara T, Kasai Y, Sudo A.

Asian Spine J. 2017 Jun;11(3):380-389. doi: 10.4184/asj.2017.11.3.380. Epub 2017 Jun 15.

44.

Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels.

Nagaharu K, Sugimoto Y, Hoshi Y, Yamaguchi T, Ito R, Matsubayashi K, Kawakami K, Ohishi K.

Transfusion. 2017 Jun;57(6):1414-1418. doi: 10.1111/trf.14088. Epub 2017 Apr 2.

PMID:
28369973
45.

Management of Pulmonary Mucormycosis Based on a Polymerase Chain Reaction (PCR) Diagnosis in Patients with Hematologic Malignancies: A Report of Four Cases.

Ino K, Nakase K, Nakamura A, Nakamori Y, Sugawara Y, Miyazaki K, Monma F, Fujieda A, Sugimoto Y, Ohishi K, Masuya M, Katayama N.

Intern Med. 2017;56(6):707-711. doi: 10.2169/internalmedicine.56.7647. Epub 2017 Mar 17.

46.

Serologic evidence of Brucella infection in pinnipeds along the coast of Hokkaido, the northernmost main island of Japan.

Abe E, Ohishi K, Ishinazaka T, Fujii K, Maruyama T.

Microbiol Immunol. 2017 Apr;61(3-4):114-122. doi: 10.1111/1348-0421.12474.

47.

Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α7 nAChR in macrophages.

Kanaoka Y, Koga M, Sugiyama K, Ohishi K, Kataoka Y, Yamauchi A.

Toxicology. 2017 Apr 1;380:62-71. doi: 10.1016/j.tox.2017.02.006. Epub 2017 Feb 12.

PMID:
28202387
48.

Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.

Komatsu N, Kirito K, Shimoda K, Ishikawa T, Ohishi K, Ohyashiki K, Takahashi N, Okada H, Amagasaki T, Yonezu T, Akashi K.

Int J Hematol. 2017 Mar;105(3):387. doi: 10.1007/s12185-017-2196-2. No abstract available.

PMID:
28176224
49.

[A Case of Advanced Rectal Cancer Resulting in a Pathologically Complete Response after Neoadjuvant Chemotherapy].

Minoji T, Murata K, Kitahara T, Okamura S, Nushijima Y, Hamano R, Yanagisawa T, Fukuchi N, Ebisui C, Yokouchi H, Kinuta M, Ohishi K.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2335-2337. Japanese.

PMID:
28133313
50.

[Right Hemi-Colectomy for a Metastatic Transverse Colon Tumor from Breast Cancer Following Bilateral Breast Cancer Resection - A Case Report].

Okamura S, Yanagisawa T, Ohishi K, Murata K, Nushijima Y, Hamano R, Fukuchi N, Ebisui C, Yokouchi H, Kinuta M.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2047-2049. Japanese.

PMID:
28133217

Supplemental Content

Loading ...
Support Center